Mesothelioma Navy Mesothelioma Navy Technology Applications 5 — Questions and Answers
Question 1: How does the VA's disability rating system handle mesothelioma claims for Navy veterans, and what presumption applies?
- Navy veterans must prove specific asbestos product brands to receive VA benefits
- Mesothelioma is rated at 100% disability and service connection is presumed for veterans with documented shipboard duty (Correct answer)
- VA benefits are unavailable for asbestos-related diseases because they predate the VA's jurisdiction
- Claims are limited to veterans who served after 1970 when records were digitized
Correct answer: Mesothelioma is rated at 100% disability and service connection is presumed for veterans with documented shipboard duty
The VA rates mesothelioma at 100% disability and presumes service connection for veterans with documented duty aboard ships where asbestos exposure was occupationally likely.
Question 2: Which imaging technology is currently used as the primary diagnostic tool for detecting malignant pleural mesothelioma in Navy veterans?
- Standard chest X-ray as the definitive diagnostic standard
- CT scan of the chest combined with PET scan for staging, followed by tissue biopsy for confirmation (Correct answer)
- MRI of the thorax alone as the gold standard
- Ultrasound-guided pleural fluid analysis as the sole diagnostic method
Correct answer: CT scan of the chest combined with PET scan for staging, followed by tissue biopsy for confirmation
CT scan with PET imaging identifies pleural thickening and tumor extent, but histological confirmation via biopsy remains essential for definitive mesothelioma diagnosis.
Question 3: What engineering principle explains why Navy boiler tenders faced the highest cumulative asbestos fiber doses among all shipboard ratings?
- Boiler tenders worked in spaces with the highest concentration of asbestos-insulated equipment at the highest operating temperatures (Correct answer)
- Boiler tenders handled asbestos-containing fuel additives unique to their rating
- Navy regulations required boiler tenders to perform insulation work without respiratory protection as a cost-saving measure
- Boiler tenders worked exclusively on aircraft carriers where asbestos density was highest
Correct answer: Boiler tenders worked in spaces with the highest concentration of asbestos-insulated equipment at the highest operating temperatures
Boiler rooms concentrated more asbestos-insulated equipment per square foot at higher temperatures than any other shipboard space, maximizing fiber release and inhalation for boiler tenders.
Question 4: In Navy mesothelioma legal claims, what is the '(substantial factor' causation standard and how does it benefit plaintiffs with multiple asbestos exposures?
- Plaintiffs must identify the single manufacturer whose product caused their cancer
- Each exposure that was a substantial contributing factor to disease development can support liability, even if other exposures also occurred (Correct answer)
- The substantial factor standard requires proving that Navy exposure was the sole cause
- This standard applies only in asbestos bankruptcy trust claims, not court litigation
Correct answer: Each exposure that was a substantial contributing factor to disease development can support liability, even if other exposures also occurred
The substantial factor standard allows plaintiffs to hold multiple manufacturers liable if each exposure meaningfully contributed to disease development, without requiring proof that any single exposure was the sole cause.
Question 5: What role did Navy technical manuals and engineering drawings play in establishing asbestos exposure evidence in mesothelioma litigation?
- Technical manuals are classified and unavailable to plaintiffs' attorneys
- Ship construction drawings and equipment manuals document which specific asbestos-containing products were installed, corroborating veterans' testimony (Correct answer)
- Technical manuals were routinely destroyed during decommissioning, eliminating documentary evidence
- Only the manufacturer's sales records, not Navy documents, are admissible to prove product identity
Correct answer: Ship construction drawings and equipment manuals document which specific asbestos-containing products were installed, corroborating veterans' testimony
Navy ship construction records, equipment specifications, and technical manuals identify exact asbestos products by manufacturer and location, providing documentary evidence to support veterans' exposure claims.
Question 6: How did the technology of spray-applied asbestos fireproofing used in Navy shipyards affect shore-based shipyard workers differently from sailors?
- Shipyard workers had lower exposure because spray was applied outdoors with natural ventilation
- Spray-applied asbestos released the highest airborne fiber concentrations of any application method, giving shipyard workers among the highest cumulative doses of any occupation (Correct answer)
- Spray application was restricted to sailor-only spaces so shipyard workers were unaffected
- Spray fireproofing used a different, non-carcinogenic asbestos variety exclusively in shipyard applications
Correct answer: Spray-applied asbestos released the highest airborne fiber concentrations of any application method, giving shipyard workers among the highest cumulative doses of any occupation
Spray application of asbestos fireproofing generated extreme airborne fiber concentrations in enclosed shipyard spaces, giving shore-based workers some of the highest documented occupational asbestos exposures.
Question 7: Which emerging immunotherapy technology has shown the most promising results in clinical trials for Navy veterans with malignant pleural mesothelioma as of the early 2020s?
- CAR-T cell therapy targeting mesothelin
- Nivolumab plus ipilimumab checkpoint inhibitor combination therapy approved by the FDA in 2020 (Correct answer)
- Bevacizumab anti-angiogenic monotherapy
- Intrapleural BCG immunostimulation
Correct answer: Nivolumab plus ipilimumab checkpoint inhibitor combination therapy approved by the FDA in 2020
The FDA approved nivolumab plus ipilimumab (Opdivo/Yervoy) combination checkpoint inhibitor therapy for unresectable mesothelioma in 2020, showing improved overall survival versus chemotherapy alone.
Mesothelioma Navy Mesothelioma Navy Technology Applications 5
How does the VA's disability rating system handle mesothelioma claims for Navy veterans, and what presumption applies?